| Issue |
Section |
Title |
File |
| Vol 7, No 1 (2011) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
USE OF TARGET DRUGS IN A HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER |
(Rus)
|
| Vol 8, No 1 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
ACTIVE OBSERVATION TACTICS IN PATIENTS WITH KIDNEY NEOPLASMS |
(Rus)
|
| Vol 8, No 1 (2012) |
PROSTATE CANCER |
THE RATE AND SITE OF LYMPH NODE METASTASES DURING RADICAL PROSTATECTOMY AND EXTENDED LYMPHADENECTOMY IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 8, No 1 (2012) |
CLINICAL CASE |
RESECTION OF THE S-SHAPED CROSSED DYSTOPIC KIDNEY IN A PATIENT WITH RENAL CELL CARCINOMA |
(Rus)
|
| Vol 12, No 2 (2016) |
PROSTATE CANCER |
Methods for the diagnosis and treatment of oligometastases in patients with prostate cancer and progressive disease after radical treatment |
(Rus)
(Eng)
|
| Vol 12, No 4 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Salvage lymphadenectomy in patients with lymphogenic prostate cancer progression after radical treatment: results of a multicenter study |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Optimization of sequential targeted therapy |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
PROSTATE CANCER |
Second-line hormonal therapy with the enzalutamid in patients with castrate-resistant prostate cancer |
(Rus)
(Eng)
|
| Vol 13, No 3 (2017) |
CLINICAL CASE |
Neoadjuvant chemohormonal therapy and radical prostatectomy in a patient with lymphogenic metastatic prostate cancer |
(Rus)
|
| Vol 13, No 2 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Targeted therapy in patients with poor-prognosis renal cell carcinoma |
(Rus)
|
| Vol 14, No 3 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
CURRENTLY AVAILABLE TREATMENT OPTIONS FOR METASTATIC RENAL CELL CARCINOMA |
(Rus)
|
| Vol 4, No 3 (2008) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Targeted therapy for advanced renal cancer with Sutent®: side effects and their management |
(Rus)
|
| Vol 16, No 4 (2020) |
CLINICAL CASE |
Large bladder leiomyoma: a case report |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Clinical significance of mutations in DNA repair genes in patients with metastatic prostate cancer |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study |
(Rus)
|
| Vol 17, No 3 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Long-term treatment outcomes of patients with non-clear cell renal cell carcinoma |
(Rus)
|
| Vol 17, No 4 (2021) |
REVIEWS |
Modern possibilities of application 99mTc-labeled prostate-specific membrane antigen ligands in prostate cancer |
(Rus)
|
| Vol 17, No 3 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Experience of using 1st line combination immunotherapy in patients with metastatic renal cell carcinoma |
(Rus)
|
| Vol 18, No 3 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Evaluation of quality of life of patients with solitary renal cancer metastases in bones before and after surgical treatment in combination with targeted therapy and without it |
(Rus)
|
| Vol 18, No 3 (2022) |
PROSTATE CANCER |
Prevalence of mutations in DNA repair genes in Russian patients with metastatic castration-resistant prostate cancer |
(Rus)
|
| Vol 19, No 1 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of cabozantinib in metastatic renal cell carcinoma patients: Russian multicenter observational study |
(Rus)
|
| Vol 20, No 2 (2024) |
CLINICAL NOTES |
Late progression of renal cell carcinoma after 32 years: clinical case |
(Rus)
|
| Vol 19, No 4 (2023) |
TOPICAL PROBLEM |
Biosimilars in the practice of modern oncologist |
(Rus)
|
| Vol 20, No 2 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Effectiveness of modern immunotherapy in combination treatment of patients with renal cancer and bone metastases |
(Rus)
|
| Vol 20, No 2 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Multicenter non-interventional study of prevalence of homologous recombination gene mutations and approaches to treatment of metastatic castration-resistant prostate cancer in Russia (ADAM) |
(Rus)
|
| Vol 20, No 3 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma |
(Rus)
|
| Vol 20, No 4 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
New capabilities of 2nd and subsequent therapy lines in metastatic urothelial cancer |
(Rus)
|
| Vol 21, No 2 (2025) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy of avelumab and axitinib depending on disease burden in patients with metastatic renal cell carcinoma: a subgroup analysis of the RAVE-Renal trial |
(Rus)
|
